Revival of the regulatory Tcell: new targets for drug development
- 1 April 2004
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 9 (7) , 310-316
- https://doi.org/10.1016/s1359-6446(03)03021-6
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- CD25+ cell depletion hastens the onset of severe disease in collagen‐induced arthritisArthritis & Rheumatism, 2003
- Control of Regulatory T Cell Development by the Transcription Factor Foxp3Science, 2003
- Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by LipopolysaccharideThe Journal of Experimental Medicine, 2003
- Infectious ToleranceThe Journal of Experimental Medicine, 2002
- CD4+CD25+ Immunoregulatory T CellsImmunity, 2002
- Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte ResponsesThe Journal of Experimental Medicine, 2001
- Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor βThe Journal of Experimental Medicine, 2001
- Regulatory T Cells in AutoimmmunityAnnual Review of Immunology, 2000
- The Emerging Role of CTLA-4 as an Immune AttenuatorImmunity, 1997
- Saying the ‘S’ word in publicImmunology Today, 1993